Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
Speaker 2: Stock Movers Report, your roundup of companies making moves in
Speaker 2: the stock market. Harnessing the power of Bloomberg Data. Let's
Speaker 2: take a look at some stocks on the move today.
Speaker 3: I'm Nathan Hager, joined by Bloomberg's Valerie Titel and Valerie
Speaker 3: I have a feeling that Nvidia is going to be
Speaker 3: a stock you're going to be watching throughout this day.
Speaker 1: Good morning, Hey, good Bernie.
Speaker 2: Nathan.
Speaker 1: Yes, it's in the news. Not for good reasons. Nvidia
Speaker 1: is down nearly two percent, down one point eight percent
Speaker 1: so far in pre market trade. Is all on the
Speaker 1: back of an FT report that China's Internet watchdog has
Speaker 1: instructed companies including Ali, Baba and byte Edance to terminate
Speaker 1: orders for one of Navidia's AI chips. This one is
Speaker 1: the RTX pro six thousand D, which sounds pretty cool,
Speaker 1: Nathan if you asked me, but Chinese Chinese firms are
Speaker 1: now banning companies from buying it and asked to also
Speaker 1: these come needs to terminate the testing of the chip. Now,
Speaker 1: this specific chip series isn't regarded as among Navidia's marquee products.
Speaker 1: Those have been banned by Washington from dispersion into China,
Speaker 1: but it's more of a high end chip that's been
Speaker 1: specifically designed for the restricted Chinese market. And the move
Speaker 1: comes after Beijing has escalated a campaign against Navidia's H
Speaker 1: twenty AI chip earlier this year, and also comes two
Speaker 1: days after China has ruled that Navidia has violated anti
Speaker 1: monopoly laws. So it does feel like China is amping
Speaker 1: up the pressure on the world's most valuable company.
Speaker 3: And I see you're watching the US listed shares of
Speaker 3: another Chinese AI company. What's going on with by Dou?
Speaker 1: Yeah, this is where the excitement is. It's all about
Speaker 1: China's own homegrown chip industry really catching some wind in
Speaker 1: its sales. So by Do is up eight percent so
Speaker 1: far in pre market trade. It was up seven percent yesterday,
Speaker 1: and it's around up around forty percent since the start
Speaker 1: of September. There's been recent upgrades from the street about
Speaker 1: their new in house chip venture now. Badu is traditionally
Speaker 1: the largest search engine operator in China, but their online
Speaker 1: advertising business has been struggling. An analysts say that this
Speaker 1: to press stock price versus other peers could add some
Speaker 1: juicy upside potential in its chip and ROBOTAXI ambitions. This
Speaker 1: is more about investors becoming more positive about China's ai
Speaker 1: own AI ambitions.
Speaker 3: Now we are seeing a huge move this morning and
Speaker 3: something of a smaller stock in terms of market cap.
Speaker 3: New Forest Energy is just going gamebusters this morning.
Speaker 1: Yeah, it's up forty three percent. It already was up
Speaker 1: yesterday forty five percent for New Forest Energy. This is
Speaker 1: all on the back of finalizing a seven year deal
Speaker 1: to supply LNG to Puerto Rico and a deal worth
Speaker 1: four billion dollars. Now, this company had been very financially
Speaker 1: constrained recently. It was facing a debt crunch, but that
Speaker 1: is no longer the case now that they signed this
Speaker 1: deal with Puerto Rico. Hence why such a huge move
Speaker 1: in the stock price in the last two days.
Speaker 3: And Eli Lilly is on the move as well this morning,
Speaker 3: kind of a out of consensus call from an analyst.
Speaker 1: Yeah, this one I found really interesting. So Eli Lilly
Speaker 1: is down half of one percent. Novo Nordisk ADRs are
Speaker 1: up one percent, and this is on the back of
Speaker 1: Eli Lilly no longer being the top pick from analysts
Speaker 1: at Berenberg for weight loss market now it's out of consensus,
Speaker 1: but Novo Nordisk is now their favored play. Analyst Carrie
Speaker 1: Holford says in her note that Novo's pipeline isn't being
Speaker 1: fully appreciated. It has fresh ammunition to fight back against
Speaker 1: Lily's zep bound drug falling recent data points in a
Speaker 1: US FDA accelerated approval for its own oral we go
Speaker 1: V drug that could be launched in early twenty twenty six.
Speaker 1: It will further differentiate Novo's a BC offering from Lily,
Speaker 1: but I thought it was important given the backdrop that
Speaker 1: Novo shares have dropped over thirty so far this year.
Speaker 1: Eli Lilly has been flat, but it has been known
Speaker 1: that Eli Lilly is more positive in the weight loss
Speaker 1: drug industry.
Speaker 2: This stock Moover's report from Bloomberg Radio. Check back with
Speaker 2: us throughout the day for the latest roundup of companies
Speaker 2: making news on Wall Street and for the latest market
Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
Speaker 2: the Bloomberg Business app.